Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Silvia Chocarro"'
Autor:
Teresa Lozano, Silvia Chocarro, Celia Martin, Aritz Lasarte-Cia, Cynthia del Valle, Marta Gorraiz, Patricia Sarrión, Marina Ruiz de Galarreta, Amaia Lujambio, Sandra Hervás-Stubbs, Pablo Sarobe, Noelia Casares, Juan J. Lasarte
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Adoptive immunotherapy with ex vivo-expanded tumor-infiltrating lymphocytes (TILs) has achieved objective clinical responses in a significant number of patients with cancer. The failure of many patients to develop long-term tumor control may be, in p
Externí odkaz:
https://doaj.org/article/4b924afc377645edac5a48967c86c9d7
Autor:
Silvia Chocarro, Paula Arana, Juana Merino, Laura Moreno, Carlos Panizo, Cristina Moreno, Francisco Guillén-Grima, Jose Antonio Delgado, Carmen Pérez-Robles, Juan J. Mata
Publikováno v:
Journal of Immunological Methods. 442:54-58
Bone marrow (BM) aspirates used for flow-cytometry (FCM) studies are usually obtained from a second aspiration, as the primary aspirate is used for morphological assessment. For this reason, the FCM samples unavoidably contain some blood; although, g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe5ccc7ccb4e8b6b4a6bcb1e5f4259c
https://doi.org/10.1016/j.jim.2016.12.006
https://doi.org/10.1016/j.jim.2016.12.006
Autor:
Patricia Sarrión, Celia Martin, Teresa Lozano, Silvia Chocarro, Amaia Lujambio, Pablo Sarobe, Marta Gorraiz, Marina Ruiz de Galarreta, Sandra Hervas-Stubbs, Juan José Lasarte, Cynthia Del Valle, Noelia Casares, Aritz Lasarte-Cia
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Frontiers in Immunology
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Adoptive immunotherapy with ex vivo-expanded tumor-infiltrating lymphocytes (TILs) has achieved objective clinical responses in a significant number of patients with cancer. The failure of many patients to develop long-term tumor control may be, in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c5b2a73b75d465a06e83b773b7ed28
https://www.frontiersin.org/article/10.3389/fimmu.2019.02990/full
https://www.frontiersin.org/article/10.3389/fimmu.2019.02990/full
Autor:
Amaia Gascue, Paula Arana, Silvia Chocarro, Laura Moreno, Juana Merino, Juan J. Mata, Cristina Moreno
Publikováno v:
Journal of Cell and Developmental Biology. 1
Antibody-mediated rejection due to anti-donor HLA antibodies is a cause of chronic rejection and poor graft survival. The pathogenic role of these antibodies has been explained by their different effects on endothelial cells. Our objective was to stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b2fe53bd47e120507860cb44694c671
https://doi.org/10.36959/596/443
https://doi.org/10.36959/596/443
Autor:
Teresa Lozano, Isabel Vivas, David A. Cano, Silvia Chocarro, Pablo Sarobe, Marta Gorraiz, José Ignacio Bilbao, Juan José Lasarte, Sandra Hervas-Stubbs, Noelia Casares, Aritz Lasarte-Cia, Kristina Iribarren
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 30(7)
Purpose To evaluate the therapeutic efficacy of irreversible electroporation (IRE) combined with the intratumoral injection of the immunogenic adjuvant poly-ICLC (polyinosinic-polycytidylic acid and poly-L-lysine, a dsRNA analog mimicking viral RNA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04715e91bc36b81daa0e9873ab539df1
https://pubmed.ncbi.nlm.nih.gov/31101416
https://pubmed.ncbi.nlm.nih.gov/31101416
Autor:
Paula Arana Berganza, Juana Merino Roncal, Cristina Moreno Parado, Carmen Pérez-Robles, Silvia Chocarro de Miguel, A. Sánchez-Ibarrola, Juan José Mata Molanes, José Antonio Delgado García, Laura Moreno Narro, Leire Burgos Rodríguez
Publikováno v:
Annals of Transplantation. 19:652-659
BACKGROUND Rejection of transplanted organs is caused by alloimmune responses, primarily against HLA molecules. Anti-donor HLA antibodies are associated with antibody-mediated rejection (AMR) and poor graft outcome. Because of clinical interest in de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4b5feb1bc239f0a526d7ecbcf88d11
https://doi.org/10.12659/aot.891359
https://doi.org/10.12659/aot.891359